KR20180044225A - 불용성 및 가용성의 옥살레이트의 분해를 위한 고효율의 옥살레이트 분해 효소 - Google Patents

불용성 및 가용성의 옥살레이트의 분해를 위한 고효율의 옥살레이트 분해 효소 Download PDF

Info

Publication number
KR20180044225A
KR20180044225A KR1020177031741A KR20177031741A KR20180044225A KR 20180044225 A KR20180044225 A KR 20180044225A KR 1020177031741 A KR1020177031741 A KR 1020177031741A KR 20177031741 A KR20177031741 A KR 20177031741A KR 20180044225 A KR20180044225 A KR 20180044225A
Authority
KR
South Korea
Prior art keywords
oxalate
enzyme
composition
activity
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020177031741A
Other languages
English (en)
Korean (ko)
Inventor
아론 비. 카울리
헬레나 카울리
퀸 얀
킹샨 리
Original Assignee
캡토자임, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 캡토자임, 엘엘씨 filed Critical 캡토자임, 엘엘씨
Publication of KR20180044225A publication Critical patent/KR20180044225A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
    • C12Y102/03004—Oxalate oxidase (1.2.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y401/00—Carbon-carbon lyases (4.1)
    • C12Y401/01—Carboxy-lyases (4.1.1)
    • C12Y401/01002—Oxalate decarboxylase (4.1.1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y401/00—Carbon-carbon lyases (4.1)
    • C12Y401/01—Carboxy-lyases (4.1.1)
    • C12Y401/01008—Oxalyl-CoA decarboxylase (4.1.1.8)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020177031741A 2015-04-02 2016-04-04 불용성 및 가용성의 옥살레이트의 분해를 위한 고효율의 옥살레이트 분해 효소 Ceased KR20180044225A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562141976P 2015-04-02 2015-04-02
US62/141,976 2015-04-02
PCT/US2016/025937 WO2016161455A2 (en) 2015-04-02 2016-04-04 High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate

Publications (1)

Publication Number Publication Date
KR20180044225A true KR20180044225A (ko) 2018-05-02

Family

ID=57007703

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177031741A Ceased KR20180044225A (ko) 2015-04-02 2016-04-04 불용성 및 가용성의 옥살레이트의 분해를 위한 고효율의 옥살레이트 분해 효소

Country Status (7)

Country Link
US (2) US11603524B2 (en:Method)
EP (1) EP3277099B9 (en:Method)
KR (1) KR20180044225A (en:Method)
CN (1) CN107960105B (en:Method)
AU (2) AU2016244121B2 (en:Method)
CA (1) CA2984763C (en:Method)
WO (1) WO2016161455A2 (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107868776A (zh) * 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 糖基化草酸脱羧酶及其制备和应用
CN108588060B (zh) * 2017-03-07 2020-12-01 武汉康复得生物科技股份有限公司 一种用丝状真菌宿主细胞表达的重组草酸脱羧酶
CN108977455B (zh) * 2018-08-01 2021-07-20 武汉康复得生物科技股份有限公司 用于生产草酸脱羧酶的重组质粒、大肠杆菌表达系统及方法和应用
CN108998462B (zh) * 2018-08-01 2021-06-18 武汉康复得生物科技股份有限公司 含锰离子重组蛋白的大肠杆菌表达系统及其应用方法
CN113447585B (zh) * 2021-06-28 2022-03-15 中国食品药品检定研究院 基于液相色谱评价体外辅助生殖用液质量的方法
WO2023091607A1 (en) * 2021-11-19 2023-05-25 The Better For You Company, Llc Oxalic acid or oxalate free inonotus obliquus extract and uses thereof
WO2023154879A2 (en) * 2022-02-11 2023-08-17 Codexis, Inc. Engineered oxalate decarboxylases

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455371A (en) 1982-03-03 1984-06-19 The Ohio State University Research Foundation Oxalate oxidase composition for assay of oxalate
US5137722A (en) 1991-01-16 1992-08-11 Allegheny-Singer Research Institute Extract and pharmaceutical composition for treatment of calcium oxalate stone disease
AU656761B2 (en) 1991-02-25 1995-02-16 Syngenta Limited Newly characterised oxalate oxidase and uses therefor
UA34467C2 (uk) 1992-11-30 2001-03-15 Зенека Лімітед Виділений та очищений днк фрагмент, що кодує оксалат-декарбоксилазу
US6187571B1 (en) 1992-12-07 2001-02-13 Biogemma Use of a DNA sequence coding for a protein capable of degrading oxalic acid as selection gene
US5945273A (en) 1997-06-03 1999-08-31 Human Genome Sciences, Inc. Human oxalyl-coa decarboxylase
US5635616A (en) 1995-06-02 1997-06-03 Human Genome Sciences, Inc. Human oxalyl-CoA decarboxylase
US5604111A (en) 1994-06-20 1997-02-18 University Of Florida Research Foundation Method and kit for detection of oxalate
US6214980B1 (en) 1994-06-20 2001-04-10 University Of Florida Materials and methods for detection of Oxalobacte formigenes
US6090628A (en) 1994-06-20 2000-07-18 University Of Florida Materials and methods for detection of Oxalobactor formigenes
US5776701A (en) 1996-05-31 1998-07-07 University Of Florida Materials and methods for detecting oxalate
US6297425B1 (en) 1997-03-21 2001-10-02 Pioneer Hi-Bred International, Inc. Gene encoding oxalate decarboxylase from aspergillus phoenices
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
DE69841200D1 (de) 1997-05-23 2009-11-12 Oxthera Inc Oxalate-abbauende mikroorganismen oder oxalate-abbauende enzyme zur verhütung der oxalate-verwandten krankheiten
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6521645B2 (en) 2000-11-20 2003-02-18 The University Of Kansas Medical Center Methods for the treatment and prevention of urinary stone disease
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US6929940B1 (en) 2002-08-20 2005-08-16 University Of Florida Research Foundation, Inc. Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use
WO2004018634A2 (en) 2002-08-20 2004-03-04 University Of Florida Polynucleotide encoding oxalate decarboxylase from aspergillus niger and methods of use
US20080311101A1 (en) * 2005-06-10 2008-12-18 Shenoy Bhami C Method to Reduce Oxalate Concentration by Administration of Oxalate Oxidase Crystals
KR20080035685A (ko) 2005-08-19 2008-04-23 나노시스, 인크. 전자 등급의 금속 나노구조체
CA2645871A1 (en) 2005-12-14 2007-06-21 Oxthera Inc PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OXALATE-ASSOCIATED DISEASE
JP5558002B2 (ja) * 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
RU2009107184A (ru) 2006-08-02 2010-09-10 Элтус Фармасьютикалз Инк. (Us) Кристаллизованная оксалатдекарбоксилаза и способы применения
WO2009087826A1 (ja) * 2008-01-04 2009-07-16 Amano Enzyme Inc. シュウ酸脱炭酸酵素の生産に利用される組換え発現プラスミドベクター及び組換え菌、並びに組換えシュウ酸脱炭酸酵素の生産方法
US8431122B2 (en) * 2009-07-02 2013-04-30 Oxthera Intellectual Property Ab Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
WO2011066282A2 (en) * 2009-11-25 2011-06-03 Captozyme, Llc Methods and compositions for treating oxalate-related conditions
CN102492683B (zh) * 2011-12-01 2013-06-12 南宁奕德环境科技有限公司 一种交联草酸脱羧酶聚集体的制备方法
US9520794B2 (en) 2012-07-25 2016-12-13 Philips Lighting Holding B.V Acceleration of output energy provision for a load during start-up of a switching power converter
JP6574414B2 (ja) * 2013-06-07 2019-09-11 アレナ ファーマシューティカルズ， インコーポレイテッド 透析のための組成物、方法、および器具
CN104606100A (zh) 2015-01-12 2015-05-13 德利宝(广州)香料有限公司 一种含洋甘菊复配杭白菊提取物香精的牙膏及其制备方法

Also Published As

Publication number Publication date
AU2021200688A1 (en) 2021-03-04
US20180362955A1 (en) 2018-12-20
CA2984763C (en) 2023-08-08
AU2021200688B2 (en) 2023-04-20
EP3277099A4 (en) 2018-10-24
EP3277099B1 (en) 2023-11-08
EP3277099A2 (en) 2018-02-07
CA2984763A1 (en) 2016-10-06
US20220298497A1 (en) 2022-09-22
CN107960105A (zh) 2018-04-24
AU2016244121A1 (en) 2017-11-23
AU2016244121B2 (en) 2020-11-05
CN107960105B (zh) 2025-05-16
EP3277099B9 (en) 2024-05-29
WO2016161455A2 (en) 2016-10-06
WO2016161455A3 (en) 2016-11-24
US11603524B2 (en) 2023-03-14

Similar Documents

Publication Publication Date Title
AU2021200688B2 (en) High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
EP1976553B1 (en) Compositions and methods for oxalate reduction
US9795657B2 (en) Methods and compositions for treating oxalate-related conditions
Taluja et al. Novel approaches in microparticulate PLGA delivery systems encapsulating proteins
IL294012B2 (en) Formulations that include recombinant acid alpha-glucosidase
CN100345535C (zh) 胰岛素控释制剂及其方法
EP2465579A1 (en) Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
WO2018181071A1 (ja) 非コラーゲン性糖タンパク質分解用組成物
Ma et al. Allergenicity, assembly and applications of ovalbumin in egg white: a review
WO2018181066A1 (ja) 新規ビフィドバクテリウム属細菌
JP2011132188A (ja) プラスミノーゲン活性化増強作用を有する乳酸菌及びその組成物
CN114561333B (zh) 一种转化支链氨基酸的工程菌及在制备治疗枫糖尿症产品中的应用
CA2735465C (en) Crystalline xylose-isomerase composition and use thereof for treatment of fructose malabsorption
CN108310371B (zh) 一种降血脂药物组合物及其用途
CN101622267B (zh) 免疫调节剂
US20240254495A1 (en) Therapeutic Engineered Microbial Cell Systems and Methods for Treating Conditions in Which Oxalate is Detrimental
JP2012140396A (ja) コレステロール低下用組成物
CN117510587A (zh) 一种预防/治疗脂代谢综合症的活性肽
Grimble Physiology of nutrient absorption
HK1152967A (en) Purification and isolation of recombinant oxalate degrading enzymes

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20171101

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210402

Comment text: Request for Examination of Application

PN2301 Change of applicant

Patent event date: 20220414

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230729

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20240227

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20230729

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I